相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Immune Epitope Database (IEDB): 2018 update
Randi Vita et al.
NUCLEIC ACIDS RESEARCH (2019)
NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data
Vanessa Jurtz et al.
JOURNAL OF IMMUNOLOGY (2017)
Identification of essential genes for cancer immunotherapy
Shashank J. Patel et al.
NATURE (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
Learning from the Proteasome How To Fine-Tune Cancer Immunotherapy
Nathalie Vigneron et al.
TRENDS IN CANCER (2017)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Jesse M. Zaretsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
2016 update of the PRIDE database and its related tools (vol 44, pg D447, 2016)
Juan Antonio Vizcaino et al.
NUCLEIC ACIDS RESEARCH (2016)
Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome
Satyendra C. Tripathi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Michal Bassani-Sternberg et al.
NATURE COMMUNICATIONS (2016)
Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells
Andrea Petretto et al.
ONCOTARGET (2016)
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens
Shelly Kalaora et al.
ONCOTARGET (2016)
Mismatch in epitope specificities between IFNy inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma
Katherine Woods et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Systematic pan-cancer analysis of tumour purity
Dvir Aran et al.
NATURE COMMUNICATIONS (2015)
ProteomeXchange provides globally coordinated proteomics data submission and dissemination
Juan A. Vizcaino et al.
NATURE BIOTECHNOLOGY (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach
Massimo Andreatta et al.
BIOINFORMATICS (2013)
The Effect of Proteasome Inhibition on the Generation of the Human Leukocyte Antigen (HLA) Peptidome
Elena Milner et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
A peptide's perspective on antigen presentation to the immune system
Jacques Neefjes et al.
NATURE CHEMICAL BIOLOGY (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Dissection of T-cell Antigen Specificity in Human Melanoma
Rikke Sick Andersen et al.
CANCER RESEARCH (2012)
Analysis of the Processing of Seven Human Tumor Antigens by Intermediate Proteasomes
Benoit Guillaume et al.
JOURNAL OF IMMUNOLOGY (2012)
Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion
Martin Christen Frolund Thomsen et al.
NUCLEIC ACIDS RESEARCH (2012)
A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy
Wenbin Ma et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Exome sequencing identifies GRIN2A as frequently mutated in melanoma
Xiaomu Wei et al.
NATURE GENETICS (2011)
Dissecting Interferon-Induced Transcriptional Programs in Human Peripheral Blood Cells
Simon J. Waddell et al.
PLOS ONE (2010)
Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules
Benoit Guillaume et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
NetMHCpan, a method for MHC class I binding prediction beyond humans
Ilka Hoof et al.
IMMUNOGENETICS (2009)
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
Luiz Gonzaga Almeida et al.
NUCLEIC ACIDS RESEARCH (2009)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses
Laurence Chapatte et al.
CANCER RESEARCH (2006)
Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation
J Chapiro et al.
JOURNAL OF IMMUNOLOGY (2006)
Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics
J Rappsilber et al.
ANALYTICAL CHEMISTRY (2003)
Microcolumns with self-assembled particle frits for proteomics
Y Ishihama et al.
JOURNAL OF CHROMATOGRAPHY A (2002)
The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome
ES Schultz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Antigen processing by the proteasome
PM Kloetzel
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
